These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder. Humar A, Hébert D, Davies HD, Humar A, Stephens D, O'Doherty B, Allen U. Transplantation; 2006 Mar 27; 81(6):856-61. PubMed ID: 16570008 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML. Transplantation; 1999 Oct 15; 68(7):997-1003. PubMed ID: 10532541 [Abstract] [Full Text] [Related]
12. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder. Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW. Am J Surg Pathol; 2014 Nov 15; 38(11):1522-9. PubMed ID: 25007145 [Abstract] [Full Text] [Related]
13. [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime]. Gómez E, Melón S, Fresno MF, Tricas L, Navascués R, de Oña M, Herreros M, Alvarez Grande J. Nefrologia; 2002 Nov 15; 22(6):574-81. PubMed ID: 12516292 [Abstract] [Full Text] [Related]
14. Posttransplant lymphoproliferative disorders in transplant recipients. Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A. Transplant Proc; 2006 Mar 15; 38(2):641-5. PubMed ID: 16549195 [Abstract] [Full Text] [Related]
15. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT. Transplant Proc; 2010 Jun 15; 42(5):1763-8. PubMed ID: 20620519 [Abstract] [Full Text] [Related]
16. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA. Transpl Infect Dis; 2016 Jun 15; 18(3):423-30. PubMed ID: 27016725 [Abstract] [Full Text] [Related]
17. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB, Wang Y, Song QJ, Shen DH. Zhonghua Bing Li Xue Za Zhi; 2012 Sep 15; 41(9):607-12. PubMed ID: 23157829 [Abstract] [Full Text] [Related]
18. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol]. Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R. G Ital Nefrol; 2003 Sep 15; 20(2):170-5. PubMed ID: 12746803 [Abstract] [Full Text] [Related]
19. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ. Am J Surg Pathol; 2006 Mar 15; 30(3):328-36. PubMed ID: 16538052 [Abstract] [Full Text] [Related]
20. Thoracic presentations of posttransplant lymphoproliferative disorders. Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA. Chest; 2004 Dec 15; 126(6):2013-20. PubMed ID: 15596707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]